| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |